Position in VCEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$240,201
-$25,101 QoQ
Shares Held
5,399
+5.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#220
of 315 holders
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cornerstone Investment Partners, LLC holds $1,900,408 across 6 Biotechnology names. VCEL ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
2,105 | $665,369 | |
| 2 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
113,739 | $272,973 | |
| 3 | TBPH |
Theravance Biopharma, Inc.
|
15,348 | $260,916 | |
| 4 | VCEL |
Vericel Corp
This page
|
5,399 | $240,201 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
13,831 | $234,712 | |
| 6 | INVA |
Innoviva, Inc.
|
9,962 | $226,237 |
All Filings in VCEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,201 | 5,399 | Shares | Sole | 2026-08-07 | |
| 2024-03-31 | $265,302 | 5,100 | Shares | Sole | 2024-04-29 | |
| 2021-03-31 | $380,239 | 6,845 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $211,373 | 6,845 | Shares | Sole | 2021-01-28 | |
| No filing history on record for this holder in this stock. | ||||||